KERX
Keryx Biopharmaceuticals Inc
KERX
KERX
Delisted
KERX was delisted on the 12th of December, 2018.
126 hedge funds and large institutions have $574M invested in Keryx Biopharmaceuticals Inc in 2017 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 48 increasing their positions, 24 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
33% more call options, than puts
Call options by funds: $6.15M | Put options by funds: $4.63M
6% more funds holding
Funds holding: 119 → 126 (+7)
Holders
126
Holding in Top 10
3
Calls
$6.15M
Puts
$4.63M
Top Buyers
| 1 | +$50.6M | |
| 2 | +$10.5M | |
| 3 | +$4.2M | |
| 4 |
MPAM
Monarch Partners Asset Management
Boston,
Massachusetts
|
+$3.06M |
| 5 |
CEP
Chicago Equity Partners
Chicago,
Illinois
|
+$2.76M |
Top Sellers
| 1 | -$3.38M | |
| 2 | -$2.54M | |
| 3 | -$907K | |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$875K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$580K |